BLTE files Form 144 for ADS sales

BLTE submitted a Form 144 notifying the proposed sale of American Depositary Shares (each representing one ordinary share).

Accepted by SEC EDGAR 04/09/2026 - 04:52 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

BLTE submitted a Form 144 notifying the proposed sale of American Depositary Shares (each representing one ordinary share). The filing lists multiple recent acquisitions via ESOP exercise and RSU vesting, including transactions of 42,811, 15,113, 7,909, 11,388, and two 20,000-share entries, dated through 11/03/2025.

Key Figures

Representative ADS entry: 42,811 shares Representative ADS entry: 15,113 shares Representative ADS entry: 7,909 shares +3 more

6 metrics

Representative ADS entry 42,811 shares ESOP Exercise dated 02/27/2025

Representative ADS entry 15,113 shares ESOP Exercise dated 03/06/2025

Representative ADS entry 7,909 shares ESOP Exercise dated 03/11/2025

RSU vesting entry 18,779 shares RSU Vesting dated 09/16/2025

RSU vesting entries 20,000 shares RSU Vesting dated 10/17/2025 and 11/03/2025 (two entries)

Header numeric fields 136,000; 24,307,280; 39,339,960 Values appearing in header row (context not defined in excerpt)

Key Terms

American Depositary Shares, ESOP Exercise, RSU Vesting, Form 144

4 terms

American Depositary Shares market

"American Depositary Shares, each representing one ordinary share"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

ESOP Exercise compensation

"02/27/2025 | ESOP Exercise | Issuer"

RSU Vesting compensation

"09/16/2025 | RSU Vesting | Issuer"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BLTE's Form 144 report?

It reports a proposed sale of American Depositary Shares by an affiliate or insider. The filing lists recent ESOP exercises and RSU vesting entries, with sample transactions such as 42,811 and 20,000 ADS recorded on specific dates in 2025.

How many ADS examples are shown in the filing for BLTE?

The excerpt shows multiple examples totaling specific line items. Representative entries include 42,811, 15,113, 7,909, 11,388, 18,779, and two 20,000-share items, with dates from 02/27/2025 to 11/03/2025.

Do the listed entries indicate how the ADS were acquired for BLTE?

Yes; the entries identify acquisition methods such as ESOP Exercise and RSU Vesting. Each line pairs the method with a specific date and a share count like 15,113 or 18,779.

Are sale proceeds or prices disclosed in BLTE's Form 144 excerpt?

No specific sale prices or aggregate proceeds are provided in the excerpt. The lines show acquisition dates, methods, and share counts but do not state dollar amounts or sale prices.

Which dates appear in BLTE's Form 144 example entries?

The excerpt lists acquisition/vesting dates including 02/27/2025, 03/06/2025, 03/11/2025, 03/12/2025, 09/16/2025, 10/17/2025, and 11/03/2025 associated with the shown ADS counts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001965964
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Belite Bio, Inc.
SEC File Number	001-41359
Address of Issuer	12750 High Bluff Drive Suite 475 San Diego CALIFORNIA 92130
Phone	858-246-6240
Name of Person for Whose Account the Securities are To Be Sold	Yu-Hsin Lin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO, Chairman

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares, each representing one ordinary share	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	136000	24307280	39339960	04/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares, each representing one ordinary share	02/27/2025	ESOP Exercise	Issuer			42811	02/26/2025	Cash
American Depositary Shares, each representing one ordinary share	03/06/2025	ESOP Exercise	Issuer			15113	03/05/2025	Cash
American Depositary Shares, each representing one ordinary share	03/11/2025	ESOP Exercise	Issuer			7909	03/12/2025	Cash
American Depositary Shares, each representing one ordinary share	03/12/2025	ESOP Exercise	Issuer			11388	03/11/2025	Cash
American Depositary Shares, each representing one ordinary share	09/16/2025	RSU Vesting	Issuer			18779	09/15/2025	N/A
American Depositary Shares, each representing one ordinary share	10/17/2025	RSU Vesting	Issuer			20000	10/16/2025	N/A
American Depositary Shares, each representing one ordinary share	11/03/2025	RSU Vesting	Issuer			20000	11/02/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	04/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Yu-Hsin Lin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)